News & Updates

Dietary interventions continue to provide benefits in the management of chronic liver diseases and serve as a valuable addition to pharmacotherapy options available, reports a study.

A recent study has demonstrated the long-term safety of mirikizumab in patients with moderate to severe active ulcerative colitis (UC), with no new significant safety concerns.

Among several social determinants of health (SDOHs), diet quality is most consistently associated with disease prevalence and severity in metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.

Yoga does not appear helpful in reducing gastrointestinal severity of symptoms, anxiety, and depression or quality of life in patients with irritable bowel syndrome (IBS), a study has shown.

For Crohn’s disease (CD) patients with suboptimal response to ustekinumab, doubling the dosing frequency from every 8 weeks to every 4 weeks elicited meaningful improvements in objective and patient-reported outcomes, as shown in a small retrospective study.

For patients with irritable bowel syndrome (IBS), practicing yoga does not help improve symptoms, anxiety, depression, and quality of life, according to a systematic review and meta-analysis.

Female sex appears to be an independent risk factor for hip fracture among individuals with inflammatory bowel disease (IBD), findings from a nationally representative study suggest.